SigTuple launched AS76, an AI-powered digital morphology analyser that processes blood smear analysi...
The AMW Read
The article details a product launch for SigTuple within the healthcare vertical, representing an incremental update to the digital pathology/diagnostics player map.
SigTuple launched AS76, an AI-powered digital morphology analyser that processes blood smear analysis entirely on-device using NVIDIA RTX edge computing. The system handles 6 slides simultaneously, delivers near-instant results without internet dependency, and preserves patient data privacy through local AI inference. This positions AS76 as a potential digital replacement for traditional microscopes in laboratories, with CE-marked IVDR compliance enabling European market entry. The digital pathology market, valued at $2.01 billion in 2026, is projected to surpass $3.2 billion by 2031 at 9.9% CAGR, driven by AI adoption accelerating diagnostics automation. AS76's edge AI architecture addresses critical challenges including pathologist shortages in underserved regions, GDPR/HIPAA compliance requirements, and rural healthcare access barriers. #EdgeAI #DigitalPathology #HealthcareAI #MedTech #NVIDIA
